search
for
 About Bioline  All Journals  Testimonials  Membership  News


Annals of African Medicine
Annals of African Medicine Society
ISSN: 1596-3519
Vol. 3, No. 1, 2004, pp. 35-37
Bioline Code: am04010
Full paper language: English
Document type: Research Article
Document available free of charge

Annals of African Medicine, Vol. 3, No. 1, 2004, pp. 35-37

 en Hepatitis C Virus Antibodies Among Blood Donors in Jos, Nigeria
Egah, D. Z.; Mandong, B. M.; Iya, D.; Gomwalk, N. E.; Audu, E. S.; Banwat, E. B. & Onile, B. A.

Abstract

Background: Hepatitis C virus (HCV) is one of the hepatitis agents known to be transmitted through blood and blood products. Hepatitis C virus has been implicated as a major cause of chronic liver disease and hepatocellular carcinoma worldwide. This study was, therefore, undertaken with the objective of determining the sero-prevalence of HCV antibodies among blood donors in the central city of Jos, Nigeria.
Method: A total of two hundred blood donors were recruited from three hospitals within Jos metropolis. Sera from all subjects were tested for Hepatitis C virus antibodies using a second generation enzyme linked immunosorbent assay (ELISA).
Results: Ninety five percent (95%)of the blood donors were males and most of them were aged between 21 and 50years. Twelve (6.0%)of the blood donors were anti-HCV seropositive and all of them males.
Conclusion: There is an urgent need to introduce routine screening of blood donors for Hepatitis C virus markers in centers where this is not currently been practiced. This will reduce the risk of transfusion-associated hepatitis C infection and its complications in Nigeria.

Keywords
Hepatitis C virus, blood donors, Jos

 
© Copyright 2004 - Annals of African Medicine.
Alternative site location: http://www.annalsafrmed.org

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil